Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes
The 2 together may help you lose more weight than either medication alone
For Type 2 diabetics on intensive insulin therapy, there is no apparent mechanism for GLP-1 drugs to alter the underlying progression of beta cell decline of these patients
A.MedaL.BonoraS.CeskaM.ConstantinG
You are 5 times more likely to die from a fall than to develop NAION
Parenteral administration is expected to dominate the market, accounting for 80% of the market share in 2026, as GLP-1 Receptor Agonists are commonly administered via injections for better absorption and efficacy
